Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by Ciaoon Nov 13, 2021 12:32pm
239 Views
Post# 34123266

BG study: other markers being looked at

BG study: other markers being looked at Here are some but not all of the other outputs that are being looked at; ">" are my notes

 
Changes in high sensitivity C-reactive protein, [ Time Frame: week 0 to week 12 ]
mg/L > marker for cardiovascular disease
 
Changes in very low-density lipoprotein cholesterol, [ Time Frame: week 0 to week 12 ]
mmol/L or mg/dL > marker for cholesterol that can build up in arteries, leading to artherosclerosis
 
Changes in apo B. [ Time Frame: week 0 to week 12 ]
mmol/L > protein involved in metabolism of lipids
 
Changes in Lipoprotein (a) (Lp(a)) [ Time Frame: week 0 to week 12 ]
mmol/L > carries cholesterol through bloodstream
 
Changes in glycated hemoglobin (HbA1c) [ Time Frame: week 0 to week 12 ]
percentage > HbA1c measures amount of blood sugar attached to hemoglobin
 

<< Previous
Bullboard Posts
Next >>